EM2001F "Biosimilars in Oncology" (IM GR-012420)
To provide clinicians with both broad and oncology specific perspectives on biosimilars.
Target Audience
UT Southwestern faculty, fellows, residents and medical students, community physicians, nurse clinicians, physician assistants and nurses.
Learning Objectives
At the conclusion of this activity, the participant should be able to:
- Explain the similarities and differences between biosimilars, reference biologics, and small molecule generics.
- Compare available safety and efficacy data for available biosimilars and reference biologics and the potential impact of interchangeability, extrapolation of indications, and substitution on dose/response, adverse events, and clinical outcomes.
- Summarize the key steps outlined by the FDA to demonstrate biosimilarity between a biosimilar and its reference biologic product.
Nisha Unni, M.D.
Assistant Professor, Department of Internal Medicine
Division of Hematology and Oncology
Available Credit
- 1.00 AMA
Price
Cost:
$0.00
Please login or create an account to take this course.
Required Hardware/software
Activities should be run with recent versions of common browsers, including Internet Explorer, Firefox and Google Chrome